References
- Karaconji T, Whist E, Jamieson RV, Flaherty MP, Grigg JRB. Neurofibromatosis type 1: review and update on emerging Therapies. Asia Pac J Ophthalmol (Phila). 2019;8(1):62–72. doi:10.22608/APO.2018182.
- Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23(8):1506–13. doi:10.1038/s41436-021-01170-5.
- Edward DP, Morales J, Bouhenni RA, Patil J, Edward PR, Cummings TJ, Chaudhry IA, AlKatan H. Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights. Ophthalmology. 2012;119(7):1485–94. doi:10.1016/j.ophtha.2012.01.027.
- Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol. 2018;63(4):518–33. doi:10.1016/j.survophthal.2017.10.007.
- Morales JCI, Bosley TM. Glaucoma and globe enlargement associated with neurofibromatosis type 1. Ophthalmology. 2009;116(9):1725–30. doi: 10.1016/j.ophtha.2009.06.019.
- Hoyt CS, Billson FA. Buphthalmos in neurofibromatosis: is it an expression of regional gigantism? J Pediatr Ophthalmol. 1977;14(4):228–34.
- Yassin S, Al-Tamimi E. Familial bilateral combined hamartoma of retina and retinal pigment epithelium associated with neurofibromatosis 1. Saudi J Ophthalmol. 2012;26(2):229–34. doi:10.1016/j.sjopt.2012.03.005.
- Lim FPM, Ho CL. Long-term treatment outcomes for congenital ectropion uveae with ptosis and glaucoma. J Am Assoc Pediatr Ophthalmol Strabismus. 2020;24(6):369–71. doi:10.1016/j.jaapos.2020.06.015.
- Wang GM, Thuente D, Bohnsack BL. Angle closure glaucoma in congenital ectropion uvea. Am J Ophthalmol Case Rep. 2018;10:215–20. doi:10.1016/j.ajoc.2018.03.009.